184 related articles for article (PubMed ID: 12355496)
1. Antiarthritic activity of an orally active C5a receptor antagonist against antigen-induced monarticular arthritis in the rat.
Woodruff TM; Strachan AJ; Dryburgh N; Shiels IA; Reid RC; Fairlie DP; Taylor SM
Arthritis Rheum; 2002 Sep; 46(9):2476-85. PubMed ID: 12355496
[TBL] [Abstract][Full Text] [Related]
2. Protective effect of a new C5a receptor antagonist against ischemia-reperfusion injury in the rat small intestine.
Arumugam TV; Shiels IA; Woodruff TM; Reid RC; Fairlie DP; Taylor SM
J Surg Res; 2002 Apr; 103(2):260-7. PubMed ID: 11922743
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of immune-complex mediated dermal inflammation in rats following either oral or topical administration of a small molecule C5a receptor antagonist.
Strachan AJ; Shiels IA; Reid RC; Fairlie DP; Taylor SM
Br J Pharmacol; 2001 Dec; 134(8):1778-86. PubMed ID: 11739255
[TBL] [Abstract][Full Text] [Related]
4. Protective effect of a human C5a receptor antagonist against hepatic ischaemia-reperfusion injury in rats.
Arumugam TV; Woodruff TM; Stocks SZ; Proctor LM; Pollitt S; Shiels IA; Reid RC; Fairlie DP; Taylor SM
J Hepatol; 2004 Jun; 40(6):934-41. PubMed ID: 15158333
[TBL] [Abstract][Full Text] [Related]
5. Increased potency of a novel complement factor 5a receptor antagonist in a rat model of inflammatory bowel disease.
Woodruff TM; Pollitt S; Proctor LM; Stocks SZ; Manthey HD; Williams HM; Mahadevan IB; Shiels IA; Taylor SM
J Pharmacol Exp Ther; 2005 Aug; 314(2):811-7. PubMed ID: 15879003
[TBL] [Abstract][Full Text] [Related]
6. Low-molecular-weight peptidic and cyclic antagonists of the receptor for the complement factor C5a.
Finch AM; Wong AK; Paczkowski NJ; Wadi SK; Craik DJ; Fairlie DP; Taylor SM
J Med Chem; 1999 Jun; 42(11):1965-74. PubMed ID: 10354404
[TBL] [Abstract][Full Text] [Related]
7. Quantitative assessment of markers of inflammation, arthritis and pain in rats with adjuvant arthritis following the treatment with ibuprofen cream and placebo.
Rovenský J; Svík K; Istok R; Stancíková M
Drugs Exp Clin Res; 2003; 29(2):85-90. PubMed ID: 12951839
[TBL] [Abstract][Full Text] [Related]
8. Selective therapeutic control of C5a and the terminal complement complex by anti-C5 single-chain Fv in an experimental model of antigen-induced arthritis in rats.
Fischetti F; Durigutto P; Macor P; Marzari R; Carretta R; Tedesco F
Arthritis Rheum; 2007 Apr; 56(4):1187-97. PubMed ID: 17393439
[TBL] [Abstract][Full Text] [Related]
9. Potent cyclic antagonists of the complement C5a receptor on human polymorphonuclear leukocytes. Relationships between structures and activity.
March DR; Proctor LM; Stoermer MJ; Sbaglia R; Abbenante G; Reid RC; Woodruff TM; Wadi K; Paczkowski N; Tyndall JD; Taylor SM; Fairlie DP
Mol Pharmacol; 2004 Apr; 65(4):868-79. PubMed ID: 15044616
[TBL] [Abstract][Full Text] [Related]
10. Blocking the receptor for C5a in patients with rheumatoid arthritis does not reduce synovial inflammation.
Vergunst CE; Gerlag DM; Dinant H; Schulz L; Vinkenoog M; Smeets TJ; Sanders ME; Reedquist KA; Tak PP
Rheumatology (Oxford); 2007 Dec; 46(12):1773-8. PubMed ID: 17965442
[TBL] [Abstract][Full Text] [Related]
11. Comparative anti-inflammatory activities of antagonists to C3a and C5a receptors in a rat model of intestinal ischaemia/reperfusion injury.
Proctor LM; Arumugam TV; Shiels I; Reid RC; Fairlie DP; Taylor SM
Br J Pharmacol; 2004 Jun; 142(4):756-64. PubMed ID: 15159277
[TBL] [Abstract][Full Text] [Related]
12. Vegfb gene knockout mice display reduced pathology and synovial angiogenesis in both antigen-induced and collagen-induced models of arthritis.
Mould AW; Tonks ID; Cahill MM; Pettit AR; Thomas R; Hayward NK; Kay GF
Arthritis Rheum; 2003 Sep; 48(9):2660-9. PubMed ID: 13130487
[TBL] [Abstract][Full Text] [Related]
13. Final report on the safety assessment of capsicum annuum extract, capsicum annuum fruit extract, capsicum annuum resin, capsicum annuum fruit powder, capsicum frutescens fruit, capsicum frutescens fruit extract, capsicum frutescens resin, and capsaicin.
Int J Toxicol; 2007; 26 Suppl 1():3-106. PubMed ID: 17365137
[TBL] [Abstract][Full Text] [Related]
14. A tumor necrosis factor receptor loop peptide mimic inhibits bone destruction to the same extent as anti-tumor necrosis factor monoclonal antibody in murine collagen-induced arthritis.
Saito H; Kojima T; Takahashi M; Horne WC; Baron R; Amagasa T; Ohya K; Aoki K
Arthritis Rheum; 2007 Apr; 56(4):1164-74. PubMed ID: 17393436
[TBL] [Abstract][Full Text] [Related]
15. Additive bone-protective effects of anabolic treatment when used in conjunction with RANKL and tumor necrosis factor inhibition in two rat arthritis models.
Schett G; Middleton S; Bolon B; Stolina M; Brown H; Zhu L; Pretorius J; Zack DJ; Kostenuik P; Feige U
Arthritis Rheum; 2005 May; 52(5):1604-11. PubMed ID: 15880601
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of C5a-induced neutrophil chemotaxis and macrophage cytokine production in vitro by a new C5a receptor antagonist.
Haynes DR; Harkin DG; Bignold LP; Hutchens MJ; Taylor SM; Fairlie DP
Biochem Pharmacol; 2000 Sep; 60(5):729-33. PubMed ID: 10927032
[TBL] [Abstract][Full Text] [Related]
17. A small molecule C5a receptor antagonist protects kidneys from ischemia/reperfusion injury in rats.
Arumugam TV; Shiels IA; Strachan AJ; Abbenante G; Fairlie DP; Taylor SM
Kidney Int; 2003 Jan; 63(1):134-42. PubMed ID: 12472776
[TBL] [Abstract][Full Text] [Related]
18. Antinociceptive effects of tumor necrosis factor alpha neutralization in a rat model of antigen-induced arthritis: evidence of a neuronal target.
Boettger MK; Hensellek S; Richter F; Gajda M; Stöckigt R; von Banchet GS; Bräuer R; Schaible HG
Arthritis Rheum; 2008 Aug; 58(8):2368-78. PubMed ID: 18668541
[TBL] [Abstract][Full Text] [Related]
19. GATA-3 protects against severe joint inflammation and bone erosion and reduces differentiation of Th17 cells during experimental arthritis.
van Hamburg JP; Mus AM; de Bruijn MJ; de Vogel L; Boon L; Cornelissen F; Asmawidjaja P; Hendriks RW; Lubberts E
Arthritis Rheum; 2009 Mar; 60(3):750-9. PubMed ID: 19248112
[TBL] [Abstract][Full Text] [Related]
20. Antiarthritic effects of relaxin, in combination with estrogen, in rat adjuvant-induced arthritis.
Santora K; Rasa C; Visco D; Steinetz BG; Bagnell CA
J Pharmacol Exp Ther; 2007 Aug; 322(2):887-93. PubMed ID: 17526806
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
